AdMeTech Annual Global Summit on Precision Diagnosis and Treatment for Prostate Cancer 2020

ai rad companion body regions

Siemens Healthineers would like to thank AdMeTech and all its contributors for their dedication to the prevention, early detection, and treatment of prostate cancer.

We are committed to enabling and empowering healthcare providers in increasing value, by working together to develop unique solutions, supporting the delivery of personalized cancer care for patients. Our prostate cancer solutions help to provide accurate staging, diagnosis, planning and treatment decisions to facilitate optimal outcomes. From AI-powered digital solutions to innovative technologies in decision support1, image interpretation, and molecular imaging, we are with you at every step of the way.

AI-Pathway Companion1 Prostate Cancer for facilitating diagnosis and treatment decisions

Actionable insights for personalized care
Leveraging data integration and augmented intelligence technologies, AI-Pathway Companion with its applications, aims to support your multidisciplinary experts’ team to ease clinical and operational decisions. AI-Pathway Companion applications enable personalized and standardized patient management and offer process improvement insights through analysis of key performance indicators2. AI-Pathway Companion helps in patient-centric clinical and operational decisions along disease-specific care pathways using augmented intelligence, data integration, and insights from cohort analytics.

Learn more

AI-Rad Companion3 Prostate MR application image annotation for urology and radiology biopsy support

Providing multi-modality imaging decision support
AI-Rad Companion Prostate MR supports in annotating images of the prostate gland for targeted MR/US-fusion biopsies and seamless information transfer to the urologist. Efficiency is gained as the AI-Rad Companion automatically segments the prostate gland, typically a tedious and time-consuming manual task. The radiologist can additionally mark potential targets for biopsy, reducing the risk for information loss.

Learn more

Molecular Imaging in prostate cancer

The Value of Molecular Imaging for Prostate Cancer
Molecular imaging techniques noninvasively provide the biological characterization of prostate cancer that anatomical modalities lack. MI modalities assess physiological aberrations in cellular metabolism and the expression of various cellular surface proteins that occur in prostate cancer, providing a more accurate depiction of disease.

Learn more

Complete the form below to request a demo for one of our Prostate Cancer Solutions



Because of some maintenance activities, this service is not available currently.
Please try again later.

An issue occurred on this form. Either, one or more missing and/or incorrect entries are in the form. Each is underlined in red. Or, the data inserted by you seems to be invalid. Please check if you filled in all form fields as expected according to the field names (e.g. ‘First Name’, ‘Last Name’ etc.). Please correct and re-submit your request again. Thank you!

An issue occurred on this form. The data inserted by you seems to be invalid. Please check if you filled in all form fields as expected according to the field names (e.g. ‘First Name’, ‘Last Name’ etc.). Please correct and re-submit your request again. Thank you!

Select your product(s) of interest:

 

* Required

Thank you for your interest in scheduling a virtual demo with Siemens Healthineers!

One of our qualified representatives will reach out to you shortly to confirm your appointment. 

Regards,

Siemens Healthineers

 

Due to technical reasons your request cannot be completed. Please try again or contact us. We apologize for the inconvenience caused.

1AI-Pathway Companion applications are not commercially available in all countries. Their future availability cannot be guaranteed. AI-Pathway Companion Prostate Cancer is CE-compliant in accordance with Directive 93/42/EEC. AI-Pathway Companion Prostate Cancer VA10B supports prostate cancer adenocarcinoma cases only.

2Functionality is supported by AI-Pathway Companion Analytics

3AI-Rad Companion applications are not commercially available in all countries. Their future availability cannot be guaranteed.